This Avenir Award program is designed to attract and support outstanding early-stage investigators in the field of chemistry and pharmacology of substance use disorders. It targets researchers who may not yet have the extensive preliminary data typically required for an R01 grant but demonstrate exceptional promise for high-impact, transformative research. The grant aims to enable these investigators to leverage recent advancements in chemical, pharmacological, and drug discovery technologies. It specifically encourages innovative projects focused on identifying novel targets, mechanisms, and pathways related to substance use disorders, and developing new therapeutic agents. This initiative seeks to foster the next generation of leaders in this crucial research area.
Opportunity ID: 338815
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-23-014 |
| Funding Opportunity Title: | Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 21, 2022 |
| Last Updated Date: | Mar 21, 2022 |
| Original Closing Date for Applications: | Aug 11, 2022 |
| Current Closing Date for Applications: | Aug 11, 2022 |
| Archive Date: | Sep 16, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) County governments Small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | oThe goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow’s leaders in the field. In recent years, there have been significant advances in methods and technologies for the identification of novel targets, mechanisms, and pathways of interest to substance use disorders and in identification of probes and optimized compounds for developing novel therapeutic agents. This FOA is to enable investigators with knowledge in the emerging chemical, pharmacological, and drug discovery technologies to pursue innovative and transformative research on chemical and pharmacological aspects of substance use disorders. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-014.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00272697 | Jul 11, 2022 | Aug 11, 2022 | View |
Package 1
Mandatory forms
338815 RR_SF424_5_0-5.0.pdf
338815 PerformanceSite_4_0-4.0.pdf
338815 RR_OtherProjectInfo_1_4-1.4.pdf
338815 RR_KeyPersonExpanded_4_0-4.0.pdf
338815 PHS398_CoverPageSupplement_5_0-5.0.pdf
338815 PHS398_ResearchPlan_4_0-4.0.pdf
338815 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338815 PHS_AssignmentRequestForm_3_0-3.0.pdf
338815 RR_Budget10_3_0-3.0.pdf
338815 RR_SubawardBudget10_30_3_0-3.0.pdf
338815 PHS398_ModularBudget_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
